Neoplasia/BPH

	Study on the prediction of postoperative metastasis in renal cancer using perirenal fat CT radiomics combined with clinical features. Front Oncol Zhou J, Zhou T, Yang Y, Zhang C, Ma Y, Xu J. PMID: 41788995 [PubMed]
	Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study. Front Oncol Pantano F, Malgeri A, De Giorgi U, Maruzzo M, Fornarini G, Zucali P, Fratino L, Milella M, Pedrazzoli P, Procopio G, Stellato M, Naglieri E, Soto Parra H, Napoli MD, Mollica V, Tudini M, Pipitone S, Santoni M, Ricotta R, Banna GL, Catalano F, Cavo A, Vignani F, Masini C, Casadei C, Galli L, Nolè F, Sorarù M, Prati V, Panni S, Roviello G, Prati G, Morelli F, Messina C, Atzori F, Rescigno P, Santini D, Buti S, Rebuzzi SE. PMID: 41788982 [PubMed]
	A phase I study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): dose escalation results. Cancer Res Commun Talmor B, Marastoni S, Lau B, Yam AO, Yeung N, Lin HM, Li ZJ, Woo H, Pranavan G, Stricker PD, Horvath LG, Koritzinsky M, Wouters BG, Crumbaker M, Joshua AM. PMID: 41788020 [PubMed - as supplied by publisher]
	Diagnostic accuracy of (68)Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer. Sci Prog Qin Z, Pan G, Huang W, Xu L, Jia R. PMID: 41787866 [PubMed - in process]
	Exercise and Phellodendron amurense extract differentially impinge on oxidative stress response pathways in a mouse model of prostate cancer. Sci Rep Patel DI, Rivas P, Chen Y, Lai Z, Ikeno Y, Kumar AP, Ghosh R. PMID: 41787055 [PubMed - as supplied by publisher]
	Comparison of prostate cancer detection rates between micro-ultrasound-guided and multiparametric magnetic resonance imaging-guided prostate biopsy: A systematic review and meta-analysis of prospective studies. Urol Oncol Lu Y, Zhao D, Han Y, Guo Y, Dong Y. PMID: 41785618 [PubMed - as supplied by publisher]
	Multifocal cohort analysis unveils cell types associated with regional lymph node seeding in prostate cancer. Genome Med de Schaetzen van Brienen L, Jung T, Larmuseau M, Van der Eecken K, Van Hecke M, Haerinck J, De Coninck J, Vanwelkenhuyzen J, Lumen N, De Laere B, De Witte N, Miclotte G, Verbeke S, Berx G, Van Dorpe J, Ost P, Marchal K. PMID: 41787470 [PubMed - as supplied by publisher]
	Glycoprotein biomarkers for bladder cancer detection. Clin Chim Acta Khan A, Alanazi FJ, Ahmed S, Alzahrani AR, Rehman ZU, Ali YH, Saeed IK, Siddique MI. PMID: 41786262 [PubMed - as supplied by publisher]
	Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial. Ann Oncol Choueiri TK, Albigès L, McDermott DF, Hammers HJ, Escudier B, Burotto M, Plimack ER, Porta C, George S, Powles T, Donskov F, Atkins MB, Gurney H, Kollmannsberger CK, Grimm MO, Barrios C, Castellano D, Grünwald V, Tomita Y, Rini BI, Jiang R, van Kooten Losio M, Lee CW, Tannir NM, Motzer RJ. PMID: 41786248 [PubMed - as supplied by publisher]
	Real-World Data on Neoadjuvant Chemotherapy for Localized Muscle-Invasive Bladder Cancer (2015-2024): A Single-Center Retrospective Study. Fr J Urol Tanguy M, Armelle P, Sheik E, Nicolas I, Caroline C, Simon B, Mikael AA, Maxime V, Stessy K. PMID: 41786089 [PubMed - as supplied by publisher]
	ICG fluorescence imaging in sentinel lymph node identification: toward a standardized protocol in paediatric renal tumour surgery. Pediatr Surg Int Wojtylko A, Garnier H, Rapala M, Murawski M, Kozakiewicz M, Jedrzejak E, Dachowska-Kalwak I, Pietras W, Czauderna P, Godzi. PMID: 41784812 [PubMed - in process]
	Efficacy of partial orchiectomy focusing on testis growth and development in prepubertal testicular tumors: a retrospective study. World J Urol Kwon SC, Lee YS, Kim SW, Lee MJ, Yoon HS, Baek JO, Han SW. PMID: 41784810 [PubMed - in process]
	[(68)Ga]PSMA-11 PET/CT vs. mpMRI in patients with a high suspicion of prostate cancer and previous negative biopsy: head to head, parallel, prospective trial (PROSPET-BX). Eur J Nucl Med Mol Imaging Lopci E, Lazzeri M, Saita A, Saitta C, Disconzi L, Colombo P, Fasulo V, Tarullo G, Vuono E, Peschechera R, Zanca R, Jandric J, Sposta FM, Scapaticci E, Paciotti M, Hurle R, Benetti A, Avolio PP, Cieri M, Zandegiacomo S, Pasini L, Casale P, Guazzoni G, Balzarini L, Laghi A, Buffi NM, Lughezzani G. PMID: 41784782 [PubMed - as supplied by publisher]
	Immune checkpoint inhibitors in bladder cancer: from mechanistic insights to emerging combination frontlines. Clin Exp Med Ajalli MM, Sansebli Y, Ekrami D, Alaeenejad F, Abbasi A, Eini P, Hassanzadeh F, Bahrami N. PMID: 41784671 [PubMed - as supplied by publisher]
	The paradox of cellular senescence in prostate cancer: from tumor suppression to tumor promotion. Front Oncol Xing Y, Qin G, Lin X, Chen S, Su Y, Lin T, Chen G. PMID: 41783438 [PubMed]
	AMACR and ZFPL1 serum biomarkers enhance precision in predicting postoperative prostate cancer outcomes. Front Oncol Yang L, Lv R, Liu Z, Chen G, Gu G. PMID: 41783436 [PubMed]
	Correction to 'Quercetin Can Be a More Reliable Treatment for Metastatic Prostate Cancer Than the Localized Disease: An InÂ Vitro Study'. J Cell Mol Med PMID: 41782225 [PubMed - in process]
	Prostate-specific antigen testing and prostate cancer-related outcomes: a Danish nationwide study. BJU Int Palshof FK, Mørch LS, Brasso K, Kroman N, Larsen SB, Røder A, Stroomberg HV. PMID: 41782199 [PubMed - as supplied by publisher]
	Changes in perceived cognitive functioning following a codesigned online group cognitive rehabilitation for prostate cancer survivors on androgen deprivation therapy: Series of single-case experimental designs. Neuropsychol Rehabil Pembroke L, Sherman KA, Dhillon HM, Francis H, Gillatt D, Gurney H. PMID: 41781343 [PubMed - as supplied by publisher]
	Reply to Letter to the Editor: 'ALBAN (GETUG-AFU 37): a phase 3, randomized, open-label, international trial of intravenous atezolizumab and intravesical Bacillus Calmette-GuÃ©rin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle invasive bladder cancer (NMIBC)' by R. Contieri et al. Ann Oncol Rouprêt M. PMID: 41781283 [PubMed - as supplied by publisher]

Articles 1 - 20 / 185976

Page 1 of 9299



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy